Recombinant INSM1 anticorps (AA 81-125)

N° du produit ABIN7876887

L’anticorps anti-INSM1 Monoclonal Lapin est utilisé pour la détection de INSM1 dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour Recombinant INSM1 anticorps (AA 81-125) (ABIN7876887)

Antigène: INSM1 (Insulinoma-Associated 1 (INSM1))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp INSM1 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: INSM1-6286R

Détail du produit anti-INSM1 anticorps

Épitope: AA 81-125

Fonction: Recombinant INSM1 Antibody / Insulinoma-associated protein 1

Purification: Protein A/G affinity

Immunogène: A portion of amino acids 81-125 was used as the immunogen for the recombinant INSM1 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the recombinant INSM1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the recombinant INSM1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur INSM1

Antigène: INSM1 (Insulinoma-Associated 1 (INSM1))

Autre désignation: INSM1

Sujet: Insulinoma-associated protein 1 (INSM1) is a developmentally regulated zinc-finger transcription factor. It localizes to the nucleus and is expressed in embryonic issues undergoing neuroendocrine differentiation. INSM1 is not expressed in normal adult tissues but can be found highly expressed in neuroendocrine tumors. INSM1 is positive in 95 % of lung small cell carcinoma and 91 % of lung large cell neuroendocrine carcinoma, compared with 75 % and 78 % with the combined panel of traditional neuroendocrine markers (synaptophysin, chromogranin, and CD56).INSM1 stains 100 % of the atypical carcinoids, typical carcinoids and paragangliomas, but only 3 % of adenocarcinomas and 4 % of squamous cell carcinomas. Therefore, INSM1 is sensitive and specific to be a single first-line pan-neuroendocrine marker.

UniProt: Q01101